Papp, Kim, et al. “Time to Loss of Response Following Withdrawal of Ixekizumab in Patients With Moderate-to-Severe Psoriasis”. Acta Dermato-Venereologica, vol. 102, Mar. 2022, p. adv00672, doi:10.2340/actadv.v102.1984.